Anglo American PLC
19 January 2007
Anglo American plc (the "Company")
Total voting rights
In accordance with the FSA's Disclosure and Transparency Rules, the Company
announces that, at 6pm on 18 January 2007:
• it had 1,541,655,681 issued ordinary shares of US$0.50 each admitted to
trading. Each ordinary share carries the right to one vote in relation to
all circumstances at general meetings of the Company;
• it held 49,956,889 ordinary shares in treasury. The voting rights of
treasury shares are automatically suspended;
• accordingly, it had total voting rights of 1,491,698,792.
The total voting rights figure (1,491,698,792) may be used by shareholders (and
others with notification obligations) as the denominator for the calculations by
which they will determine whether they are required to notify their interest in,
or a change to their interest in, the Company under the FSA's Disclosure and
Transparency Rules.
Andy Hodges
Deputy Company Secretary
Anglo American plc
19 January 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.